Orthobiologics company completes 250 cases with OsteoCrete magnesium-based bone void filler: 3 notes

Written by Shayna Korol | October 02, 2018 | Print  |

Bone Solutions Inc. announced first 250 cases of its magnesium-based bone void filler OsteoCrete were implanted.

Here are three things to know:

1. OsteoCrete is the first bone void filler in the U.S. to incorporate magnesium. It is designed to facilitate bone repair and generation.

2. OsteoCrete is designed to be completely resorbable.

3. BSI is an orthobiologics company focused on magnesium oxide-based technologies for a variety of orthopedic applications.

More articles on biologics:
Maryland Stem Cell Research Fund awards 1st round of $8.2M funding initiative: 5 things to know
5 things to know about the global orthobiologics market
Kuros Biosciences appoints 5 spine surgeons to advisory board

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months